GNTLFGenetic Technologies Ltd.

$0.00
$0.00
(0.00%)
Today
Updated: 02:42 PM EDT
Reported EarningsFeb 25
Mkt Cap$1,300.00
Vol2,000.00

About

Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Maroochydore, Australia.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Genetic Technologies Ltd.?
What is the 52-week high for Genetic Technologies Ltd.?
What was Genetic Technologies Ltd. stock price yesterday?

Latest GNTLF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.